Back

BNP as a biomarker in adult congenital heart disease: help or hype?

European Heart Journal

14 June 2024
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Congenital Heart Disease and Paediatric Cardiology

Contributors

A Mark Richards
A Mark Richards

Author

You may be interested in
thumbnail
Congress Presentation
The use of biomarkers to personalise treatment in congenital heart disease
1 September 2024
thumbnail
Congress Presentation
Pro-inflammatory intermediate monocytes relate to right ventricular pressure in heart failure of adult congenital heart disease
3 September 2019
thumbnail
Congress Presentation
Cost effectiveness of heart failure investigations in a tertiary hospital in Ireland
29 June 2021
thumbnail
Congress Presentation
Predictive value of NT-proBNP in non-obstructive hypertrophic cardiomyopathy
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources